Low-dose anti-thymocyte globulin plus low-dose posttransplant cyclophosphamide as graft-versus-host disease prophylaxis in haploidentical peripheral blood stem cell transplantation combined with unrelated cord blood for patients with hematologic malignancies: a prospective, phase II study

Nowadays, the most wildly used regimens for graft-versus-host disease (GvHD) prophylaxis in haplo-hematopoietic stem cell transplantation (Haplo-HSCT) are based on in vivo T-cell depletion (TCD) with anti-thymocyte globulin (ATG) or posttransplant cyclophosphamide (PTCy). To improve the efficiency o...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jun, Jiang, Jieling, Cai, Yu, Li, Su, Wan, Liping, Zhu, Jun, Liu, Huixia, Shao, Shan, Bai, Haitao, Wang, Chun, Song, Xianmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6760546/
https://www.ncbi.nlm.nih.gov/pubmed/30446741
http://dx.doi.org/10.1038/s41409-018-0382-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6760546/
https://www.ncbi.nlm.nih.gov/pubmed/30446741
http://dx.doi.org/10.1038/s41409-018-0382-3

Ejemplares similares